The Stemness Phenotype Model

The identification of a fraction of cancer stem cells (CSCs) associated with resistance to chemotherapy in most solid tumors leads to the dogma that eliminating this fraction will cure cancer. Experimental data has challenged this simplistic and optimistic model. Opposite to the classical cancer stem cell model, we introduced the stemness phenotype model (SPM), which proposed that all glioma cells possess stem cell properties and that the stemness is modulated by the microenvironment. A key prediction of the SPM is that to cure gliomas all gliomas cells (CSCs and non-CSCs) should be eliminated at once. Other theories closely resembling the SPM and its predictions have recently been proposed, suggesting that the SPM may be a useful model for other type of tumors. Here, we review data from other tumors that strongly support the concepts of the SPM applied to gliomas. We include data related to: (1) the presence of a rare but constant fraction of CSCs in established cancer cell lines, (2) the clonal origin of cancer, (3) the symmetrical division, (4) the ability of “non-CSCs” to generate “CSCs,” and (5) the effect of the microenvironment on cancer stemness. The aforenamed issues that decisively supported the SPM proposed for gliomas can also be applied to breast, lung, prostate cancer, and melanoma and perhaps other tumors in general. If the glioma SPM is correct and can be extrapolated to other types of cancer, it will have profound implications in the development of novel modalities for cancer treatment.

[1]  Alexander Roesch,et al.  A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth , 2010, Cell.

[2]  J. A. Burch,et al.  Melanoma, a tumor based on a mutant stem cell? , 2006, The Journal of investigative dermatology.

[3]  Noemi Andor,et al.  Asymmetry-defective oligodendrocyte progenitors are glioma precursors. , 2011, Cancer cell.

[4]  Reigh-Yi Lin.  Thyroid cancer stem cells , 2011, Nature Reviews Endocrinology.

[5]  A. Heimberger,et al.  Immune therapeutic targeting of glioma cancer stem cells , 2010, Targeted Oncology.

[6]  K. Deisseroth,et al.  Dynamics of Retrieval Strategies for Remote Memories , 2011, Cell.

[7]  Roni Shouval,et al.  Intratumoral Heterogeneity in the Self‐Renewal and Tumorigenic Differentiation of Ovarian Cancer , 2012, Stem cells.

[8]  M. Ballmaier,et al.  Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line , 2007, Molecular and Cellular Biochemistry.

[9]  T. Sørlie,et al.  Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution , 2009, Molecular oncology.

[10]  Jia-kun Zheng,et al.  The biological characteristics of glioma stem cells in human glioma cell line SHG44. , 2011, Molecular medicine reports.

[11]  C. D. Salcido,et al.  Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer , 2010, British Journal of Cancer.

[12]  Zhiwei Wang,et al.  Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy. , 2011, Anticancer research.

[13]  A. Chalmers,et al.  Radioresistance of glioma stem cells: Intrinsic characteristic or property of the ‘microenvironment‐stem cell unit’? , 2011, Molecular oncology.

[14]  W. Gu,et al.  Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability , 2011, Cancer Gene Therapy.

[15]  N. Sato,et al.  SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity , 2011, Laboratory Investigation.

[16]  J. Han,et al.  Isolation and Characterization of Spheroid Cells from Human Malignant Melanoma Cell Line WM-266-4 , 2009, Tumor Biology.

[17]  P. Carmeliet,et al.  A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours , 2011, Nature.

[18]  Wei-ru Xu,et al.  Oxymatrine diminishes the side population and inhibits the expression of β-catenin in MCF-7 breast cancer cells , 2011, Medical oncology.

[19]  C. Lightdale,et al.  Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. , 2012, Cancer cell.

[20]  Caterina A M La Porta,et al.  Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. , 2007, European journal of cancer.

[21]  J. Laterra,et al.  Cancer stem cells: distinct entities or dynamically regulated phenotypes? , 2012, Cancer research.

[22]  Angelo L. Vescovi,et al.  Brain tumour stem cells , 2006, Nature Reviews Cancer.

[23]  M. Frank,et al.  The therapeutic promise of the cancer stem cell concept. , 2010, The Journal of clinical investigation.

[24]  Jiri Bartek,et al.  Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth , 2012, The Journal of experimental medicine.

[25]  M. Cleary,et al.  HIF induces human embryonic stem cell markers in cancer cells. , 2011, Cancer research.

[26]  F. Hu,et al.  Comparative study on the stem cell phenotypes of C6 cells under different culture conditions. , 2011, Chinese medical journal.

[27]  C. Brennan,et al.  Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. , 2010, Cell stem cell.

[28]  Louis Vermeulen,et al.  Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.

[29]  Xiangjiao Meng,et al.  Both CD133+ and CD133− subpopulations of A549 and H446 cells contain cancer‐initiating cells , 2009, Cancer science.

[30]  A. Long,et al.  A human cell line from a pleural effusion derived from a breast carcinoma. , 1973, Journal of the National Cancer Institute.

[31]  K. Pantel,et al.  The Interrelating Dynamics of Hypoxic Tumor Microenvironments and Cancer Cell Phenotypes in Cancer Metastasis , 2012, Cancer Microenvironment.

[32]  L. Mariani,et al.  Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment , 2009, Proceedings of the National Academy of Sciences.

[33]  T. Kondo,et al.  Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Lenz,et al.  Extracellular ATP reduces tumor sphere growth and cancer stem cell population in glioblastoma cells , 2011, Purinergic Signalling.

[35]  D. McConkey,et al.  Bladder cancer stem cells. , 2010, Current stem cell research & therapy.

[36]  H. Li,et al.  Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells , 2006, Oncogene.

[37]  G. Hutchins,et al.  Henrietta Lacks, HeLa cells, and cell culture contamination. , 2009, Archives of pathology & laboratory medicine.

[38]  Guy S. Salvesen,et al.  SnapShot: Caspases , 2011, Cell.

[39]  H. Kornblum,et al.  Brain Tumor Stem Cells as Therapeutic Targets in Models of Glioma , 2010, Yonsei medical journal.

[40]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[41]  Mohamed H. Sayegh,et al.  Identification of cells initiating human melanomas , 2008, Nature.

[42]  L. Kopelovich,et al.  Establishment of human cancer cell clones with different characteristics: a model for screening chemopreventive agents. , 2007, Anticancer research.

[43]  J. Menéndez,et al.  Pharmacological mimicking of caloric restriction elicits epigenetic reprogramming of differentiated cells to stem-like self-renewal states. , 2010, Rejuvenation research.

[44]  Frank Pajonk,et al.  The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. , 2006, Journal of the National Cancer Institute.

[45]  L. Buzanska,et al.  Influence of low oxygen tensions on expression of pluripotency genes in stem cells. , 2011, Acta neurobiologiae experimentalis.

[46]  C. Simón,et al.  Overcoming Challenges of Ovarian Cancer Stem Cells: Novel Therapeutic Approaches , 2012, Stem Cell Reviews and Reports.

[47]  Carlos Caldas,et al.  Alpha‐6 integrin is necessary for the tumourigenicity of a stem cell‐like subpopulation within the MCF7 breast cancer cell line , 2008, International journal of cancer.

[48]  K. Skorecki,et al.  Niche-Dependent Tumorigenic Capacity of Malignant Ovarian Ascites-Derived Cancer Cell Subpopulations , 2009, Clinical Cancer Research.

[49]  E. Hurt,et al.  CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis , 2008, British Journal of Cancer.

[50]  Jun Dong,et al.  Targeting glioma stem cells: enough to terminate gliomagenesis? , 2011, Chinese medical journal.

[51]  John R Mackey,et al.  Senescence evasion by MCF-7 human breast tumor-initiating cells , 2010, Breast Cancer Research.

[52]  J Laterra,et al.  Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition , 2011, Oncogene.

[53]  Feng Jiang,et al.  Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer , 2009, Molecular Cancer Research.

[54]  More than 45% of A549 and H446 cells are cancer initiating cells: evidence from cloning and tumorigenic analyses. , 2009, Oncology reports.

[55]  G. B. Pierce,et al.  MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS. , 1964, Cancer research.

[56]  Barry H. Smith,et al.  A continuous tumor‐cell line from a human lung carcinoma with properties of type II alveolar epithelial cells , 1976, International journal of cancer.

[57]  Yuh-Lih Chang,et al.  Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells , 2008, PloS one.

[58]  J. Rich,et al.  Hypoxia and hypoxia inducible factors in cancer stem cell maintenance. , 2010, Current topics in microbiology and immunology.

[59]  L. Ricci-Vitiani,et al.  Colon cancer stem cells , 2007, Gut.

[60]  V. Stefanović,et al.  Urothelial Cancer Stem Cells , 2010, TheScientificWorldJournal.

[61]  C. Mabel,et al.  Are all Glioma Cells Cancer Stem Cells , 2010 .

[62]  K. Camphausen,et al.  The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells. , 2012, Neoplasia.

[63]  Daniel J. Hoeppner,et al.  Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions , 2011, Cell Death and Disease.

[64]  A. Tsirigos,et al.  Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer , 2011, Cell cycle.

[65]  Xiaowei Yin,et al.  Subpopulations of Stem-like Cells in Side Population Cells from the Human Bladder Transitional Cell Cancer Cell Line T24 , 2009, The Journal of international medical research.

[66]  M. Moore,et al.  Evidence for the clonal origin of chronic myeloid leukemia from a sex chromosome mosaic: clinical, cytogenetic, and marrow culture studies. , 1974, Blood.

[67]  N. Maitland,et al.  Prospective identification of tumorigenic prostate cancer stem cells. , 2005, Cancer research.

[68]  M. Matin,et al.  Cancer stem cells and cancer therapy , 2011, Tumor Biology.

[69]  M. Russo,et al.  Cell-to-Cell Signaling Influences the Fate of Prostate Cancer Stem Cells and Their Potential to Generate More Aggressive Tumors , 2012, PloS one.

[70]  J. Troge,et al.  Tumour evolution inferred by single-cell sequencing , 2011, Nature.

[71]  J. Troge,et al.  Inferring tumor progression from genomic heterogeneity. , 2010, Genome research.

[72]  Yi Shen,et al.  Hepatocellular carcinoma stem cells: origins and roles in hepatocarcinogenesis and disease progression. , 2012, Frontiers in bioscience.

[73]  O. Podhajcer,et al.  Subpopulations of MCF7 cells separated by Percoll gradient centrifugation: a model to analyze the heterogeneity of human breast cancer. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[74]  R. McLendon,et al.  The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype , 2009, Cell cycle.

[75]  G. Camussi,et al.  Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. , 2011, Cancer research.

[76]  L. Levine,et al.  Differentiated Rat Glial Cell Strain in Tissue Culture , 1968, Science.

[77]  J. Liu.  Characterization of cancer stem-like cells in chordoma , 2012 .

[78]  S. Krishna,et al.  Cancer stem cells: an approach to identify newer therapeutic targets. , 2009, Journal of stem cells.

[79]  A. Stembalska,et al.  Cancer stem cells: the theory and perspectives in cancer therapy , 2010, Journal of Applied Genetics.

[80]  M. Brattain,et al.  Heterogeneity of malignant cells from a human colonic carcinoma. , 1981, Cancer research.

[81]  Stephen Lam,et al.  Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. , 2007, Cancer research.

[82]  W. Han,et al.  Berberine Diminishes the Side Population and ABCG2 Transporter Expression in MCF-7 Breast Cancer Cells , 2008, Planta medica.

[83]  Max S Wicha,et al.  Cancer stem cells: an old idea--a paradigm shift. , 2006, Cancer research.

[84]  S. Jonjić,et al.  Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.

[85]  S. Morrison,et al.  Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. , 2010, Cancer cell.

[86]  A. A. Abd El-Aty,et al.  Characterization of a stem cell population in lung cancer A549 cells. , 2008, Biochemical and biophysical research communications.

[87]  J. Bubeník,et al.  Established cell line of urinary bladder carcinoma (T24) containing tumour‐specific antigen , 1973, International journal of cancer.

[88]  C. Pérez-Plasencia,et al.  Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance , 2012, BMC Cancer.

[89]  S. Lyle,et al.  Quiescent, Slow-Cycling Stem Cell Populations in Cancer: A Review of the Evidence and Discussion of Significance , 2010, Journal of oncology.

[90]  G. Botchkina,et al.  Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line. , 2008, Cancer genomics & proteomics.

[91]  D. Richel,et al.  The developing cancer stem-cell model: clinical challenges and opportunities. , 2012, The Lancet. Oncology.

[92]  A. Poggi,et al.  Comparative Analysis of DNA Repair in Stem and Nonstem Glioma Cell Cultures , 2009, Molecular Cancer Research.

[93]  Xiaofeng Yang,et al.  Most C6 cells are cancer stem cells: evidence from clonal and population analyses. , 2007, Cancer research.

[94]  Richard O C Oreffo,et al.  Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions , 2010, Reproduction.

[95]  D. Neal,et al.  CD133, a novel marker for human prostatic epithelial stem cells , 2004, Journal of Cell Science.

[96]  V. Mazzaferro,et al.  Evidence of Distinct Tumour-Propagating Cell Populations with Different Properties in Primary Human Hepatocellular Carcinoma , 2011, PloS one.

[97]  S. Spechler,et al.  Acid, bile, and CDX: the ABCs of making Barrett's metaplasia. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[98]  Huan Yang,et al.  Biologic characteristics of the side population of human small cell lung cancer cell line H446. , 2010, Chinese journal of cancer.

[99]  J. Dou,et al.  Isolation and identification of cancer stem-like cells from murine melanoma cell lines. , 2007, Cellular & molecular immunology.

[100]  K. Struhl,et al.  Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion , 2011, Proceedings of the National Academy of Sciences.

[101]  S. White,et al.  RNAi-mediated chromatin silencing in fission yeast. , 2008, Current topics in microbiology and immunology.